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Peer review under rwww.sciencedirect.comEditorialBile acids have been traditionally viewed as detergent molecules
involved in the solubilization and absorption of lipids and lipid-
soluble vitamins from the intestines. However, as a result of
intensive research over the past two decades, bile acids are now
viewed as endocrine signaling molecules that activate speciﬁc
nuclear receptors and G-protein coupled receptors regulating
nutrient metabolism in the liver and intestines. The year 2015
marks the 20-year anniversary of the cloning and discovery of
farnesoid X receptor (NR4H1; FXR). FXR is a main bile acid
nuclear receptor and plays an essential role in the regulation of bile
acids, lipids, glucose and drug metabolism, as well as inhibiting
inﬂammation and suppressing carcinogenesis in the liver and
intestine. Bile acids also activate pregnane X receptor, constitutive
androstane receptor, vitamin D receptor, G protein–coupled bile
acid receptor (TGR5), and sphingosine-1-phosphate receptor 2
(S1PR2) to regulate growth and functions of hepatocytes, cholan-
giocytes and enterocytes. Moreover, bile acids also induce, via
FXR, critical regulators of metabolism, inﬂammation and carcino-
genesis in the liver and intestine, including small heterodimer
partner (SHP) and ﬁbroblast growth factor 15/19 (FGF15/19). Theory
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esponsibility of Institute of Materia Medica, Chinese Acregulation of bile acid homeostasis is subject to traditional gene
promoter regulation, posttranscriptional modulation and epigenetic
regulation.
Historically, bile acids have been used as medicines around the
world. Identiﬁcation of new signaling pathways mediated by bile
acids and bile acid derivatives should result in optimizing the
current standard therapy for hepatic disorders and developing
novel therapeutic targets for various liver diseases and metabolic
syndrome.
In this issue, we have gathered leading experts in bile acid
research around the world to provide the most comprehensive and
timely review of bile acids, their receptors and regulated pathways/
functions with a focus on liver and the gastrointestinal area. These
in-depth reviews will provide the researchers, clinicians and
pharmaceutical entrepreneurs the background knowledge for
targeting bile acid–mediated signaling pathways to prevent and
treat hepatic, intestinal, and metabolic disorders.Grace L. Guo, Huiping ZhouCBAs and insulin activates phosphoinositide-dependent protein kinase
1 (PDK1), which activates protein kinase C ζ (PKCζ). PKCζ then
phosphorylates the farnesoid X receptor (FXR) allowing it to translocate
to the nucleus. FXR is activated by bile acids causing the induction of a
number of genes involved in bile acid metabolism and transport. Bile
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